SE8904384D0 - PHARMACEUTICAL COMPOSITION - Google Patents

PHARMACEUTICAL COMPOSITION

Info

Publication number
SE8904384D0
SE8904384D0 SE8904384A SE8904384A SE8904384D0 SE 8904384 D0 SE8904384 D0 SE 8904384D0 SE 8904384 A SE8904384 A SE 8904384A SE 8904384 A SE8904384 A SE 8904384A SE 8904384 D0 SE8904384 D0 SE 8904384D0
Authority
SE
Sweden
Prior art keywords
cimetidine
pirenzepine
pharmaceutical composition
pref
compsn
Prior art date
Application number
SE8904384A
Other languages
Swedish (sv)
Other versions
SE8904384L (en
Inventor
H O Kohler
Original Assignee
Corint Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corint Ltd filed Critical Corint Ltd
Priority to SE8904384A priority Critical patent/SE8904384L/en
Publication of SE8904384D0 publication Critical patent/SE8904384D0/en
Publication of SE8904384L publication Critical patent/SE8904384L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Orally administrable pharmaceutical compsn. for treating gastrointestinal dysfunction comprises the antimuscarnic agent pirenzipine and the H2-receptor antagonist cimetidine. Pref. the wt. ratio of pirenzepine to cimetidine is 1:12 to 1:5, esp. 1:12. The compsn. is pref. in the form of an orally administered tablet, comprising 300 mg cimetidine and 25 mg pirenzepine, or 600 mg cimetidine and 50mg pirenzepine.
SE8904384A 1989-12-28 1989-12-28 Oral compsn. for treating gastrointestinal dysfunction - contg. cimetidine and pirenzepine, pref. in a wt. ratio of 1:12 SE8904384L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE8904384A SE8904384L (en) 1989-12-28 1989-12-28 Oral compsn. for treating gastrointestinal dysfunction - contg. cimetidine and pirenzepine, pref. in a wt. ratio of 1:12

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8904384A SE8904384L (en) 1989-12-28 1989-12-28 Oral compsn. for treating gastrointestinal dysfunction - contg. cimetidine and pirenzepine, pref. in a wt. ratio of 1:12

Publications (2)

Publication Number Publication Date
SE8904384D0 true SE8904384D0 (en) 1989-12-28
SE8904384L SE8904384L (en) 1991-06-29

Family

ID=20377891

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8904384A SE8904384L (en) 1989-12-28 1989-12-28 Oral compsn. for treating gastrointestinal dysfunction - contg. cimetidine and pirenzepine, pref. in a wt. ratio of 1:12

Country Status (1)

Country Link
SE (1) SE8904384L (en)

Also Published As

Publication number Publication date
SE8904384L (en) 1991-06-29

Similar Documents

Publication Publication Date Title
EA200100870A1 (en) COMPOSITION-INHIBITORS OF CYCLOOXYGASE-2 WITH FAST ACCURRENT THERAPEUTIC ACTION
DE69130529D1 (en) TREATMENT OF ERECTIONAL FAILURE
KR870005637A (en) Drug depot
ES517444A0 (en) PROCEDURE FOR OBTAINING HIGHLY SOLUBLE MEDICINES BY ATOMIZATION IN THE PRESENCE OF A STABILIZER AND A CRYSTAL FORMATION INHIBITING AGENT.
BR9911060A (en) Compositions comprising organic mono- or dinitrate to treat impotence
EP0354992A3 (en) Conjugates of VIP and active fragments thereof with hydrophobic moieties and topical compositions for use in the treatment of male impotence
ATE293451T1 (en) TREATMENT OF OSTEOARTHRITIS BY ADMINISTRATION OF POLY-N-ACETYL-D-GLUCOSAMINE
JPS5234935A (en) Medicinal composition
MY120318A (en) Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses.
FR2710267B3 (en) Composition for the treatment of male impotence.
KR900005974A (en) Sexual Dysfunction in Men
SE8904384D0 (en) PHARMACEUTICAL COMPOSITION
MX9705916A (en) Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc.
IT1238674B (en) Oral compsn. for treating gastrointestinal dysfunction
JPS5233269A (en) Skid rails having stoppers to prevent collision between pipes
KR890009868A (en) Trometamine salt of 1-methyl-β-oxo-α- (phenylcarbamoyl) -2-pyrrolepropionitrile
EP0345883A3 (en) Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine
KR880009652A (en) Therapeutic rheumatoid arthritis using 3-5-dichloro methotrexate and compositions useful therein
KR870009723A (en) Use of hygromycin in the treatment and prevention of swine dysentery
SE9700617D0 (en) New composition
KR910014121A (en) Cimetidine-pyrenzepine formulation for the treatment of gastric ulcer and erosion
AU2712799A (en) The use of estradiol derivatives for treating side-effects during and/or after gnrha therapy
GB8928609D0 (en) Pharmaceutical composition
FR2313923A1 (en) Compsn. contg. sodium noramidopyrin mesylate monohydrate - also contg. chlormezanone and meprobamate, having analgesic, antiinflammatory, muscle-relaxant and anxiolytic activity
IT7824580A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF STATES OF MALE IMPOTENCE AND ALTERED PSYCHIC STATES.